MSM: Kids roll up sleeves for H1N1 clinical trial

(CNN) – Because the younger population, from 6 months to 24 years, is at high risk of developing complications from the H1N1 virus, the National Institutes of Health is conducting a clinical trial specifically to make sure the vaccine is safe for children. Vaccine developers hope to get the doses out by mid-October, before the flu season really shifts into high gear.

Lawsuit Charges Baxter Used Dangerous Ingredients In Vaccines To Increase Profits

A scandal dating from January 2008, that is continuing to unfold, raises more disturbing questions over the safety of U.S. pharmaceutical company Baxter International’s vaccines.